CII
VSTM icon

CR Intrinsic Investors’s Verastem VSTM Stock Holding History

CR Intrinsic Investors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-26,815
Closed -$4M – 367
2013
Q3 		$4M Buy
+26,815
New +$4.68M 0.12% 224

Other funds holding VSTM

DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CR Intrinsic Investors's VSTM Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Verastem (VSTM) in Q4 2013, closing a stake of 26,815 shares — an estimated $4M sold.

CR Intrinsic Investors first reported a position in VSTM in Q3 2013 and held it in 1 quarter. The position peaked at $4M in Q3 2013. 71 funds tracked by Wall St. Rank hold VSTM as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Verastem position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 26,815 Verastem shares in Q4 2013, an estimated $4M.
  • CR Intrinsic Investors first reported a position in Verastem in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Verastem position peaked at $4M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Verastem as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.